Loading...

PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC Business Restructuring 8-K Filing

PCFC

PCB

PACIFIC BIOSCIENCES OF CALIFORNIA INC

(PACB)

2025 8-K

Management Changes

Board Appointment

Financial Results Announced

Management Changes

Asset Sale Completed

Financial Results Update

Third Quarter Results

Financial Statements

Financial Statements

Workforce Reductions

Management Change

Lease Amendment

Financial Results

Management Changes

Financial Update

Executive Changes

Management Change

Management Change

Management Change

Financial Results

Debt Exchange Agreement

Expense Reduction Plan

Financial Results Announcement

Equity Incentive Plan Amend...

Financial Results Announcement

Financial Update

Financial Results Announcement

Financial Results Announcement

Resignation of Director

Financial Results Announcement

Appointment of Director and...

Appointment of Director

Financial Results and Acqui...

Exchange of Convertible Sen...

Agreement and Exchange Tran...

Annual Meeting Voting Results

Financial Results Announcement

Financial Results Announcement

Agreement for Stock Offering

Financial Update

External Links:

On April 9, 2025, Pacific Biosciences announced workforce reductions and preliminary financial results for Q1 2025, estimating a $45-$50 million reduction in annual operating expenses with $5 million in associated costs for severance and benefits.

AI Assistant

PACIFIC BIOSCIENCES OF CALIFORNIA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.